Search

Your search keyword '"Roche Holding Ltd. -- Product information"' showing total 69 results
Start Over Descriptor "Roche Holding Ltd. -- Product information"
69 results on '"Roche Holding Ltd. -- Product information"'

1. Larger size Deflatine launched

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Roche has added a 36-tablet pack size to its Rennie Deflatine range. The new pack retails at #4.79. Roche Consumer Health. Tel: 01707 [...]

Published
2000

2. Oseltamivir Phosphate Capsules (Tamiflu--Roche Pharmaceuticals)

Author

Elliott, William T. and Chan, James

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Health, Tamiflu (Medication) -- Marketing
Abstract

IN OCTOBER, THE FDA APPROVED OSELTAMVIR (TAMI-flu--Roche), the second neuraminidase inhibitor for the treatment of influenza. This comes three months after the FDA approved zanamivir (Relenza) (Intern Med Alert 1999;21:133). [...]

Published
1999

3. Solutions for DNA copy-number analysis

Author

Ott, Vanessa L.

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Biotechnology industry, Business
Abstract

Roche's NimbleGen comparative genomic hybridization arrays enable genome-wide detection of DNA copy-number changes. The system requires minimal investment and no pror microarray experience. Other product features and dimensions are also supplied.

Published
2009

4. High-performance melting curve analysis

Author

Hoffman, Michael, Hurlebaus, Jochen, and Weilke, Christian

Subjects
Roche Holding Ltd. -- Product information, Genetic variation -- Research, Gene mutations -- Research, Biotechnology laboratories -- Equipment and supplies, Polymerase chain reaction -- Equipment and supplies, Pharmaceutical industry -- Product information, Biotechnology industry, Business
Abstract

Roche has developed the LightCycler 480 System, a drug discovery and genetic variation analysis platform which offers high-perfomance analysis of melting curve. It is the only plate-based real-time polymerase chain reaction (PCR) system that can scan mutation through high-performance melting curve analysis. Its various features and uses are discussed.

Published
2007

5. Roche's Tamiflu drug may not be approved in Europe by winter

Subjects
Europe -- Science and technology policy, Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Business, Business, general, Tamiflu (Medication) -- Laws, regulations and rules
Published
2000

6. Roche defers Tamiflu approval

Subjects
Roche Holding Ltd. -- Product information, Gilead Sciences Inc. -- Product information, Pharmaceutical industry -- Product information, Influenza vaccines -- Evaluation, Business, Business, general, Tamiflu (Medication) -- Evaluation
Published
2000

7. Heart drug boosts survival of patients, study suggests

Subjects
SmithKline Beecham PLC -- Product information, Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Heart failure -- Drug therapy, Business, Business, general, Carvedilol (Medication) -- Testing
Published
2000

9. Rethink on beta blocker use in heart failure needed

Subjects
Roche Holding Ltd. -- Product information, Adrenergic beta blockers -- Care and treatment, Pharmaceutical industry -- Care and treatment, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Beta blockers, once contra-indicated in heart failure, are now emerging as a potential treatment for the condition that could improve prospects for over half a million sufferers in the UK. [...]

Published
1999

10. Roche's studies on lipodystrophy syndrome

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Protease inhibitors -- Research, HIV infection -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Abstract

Roche's HIV protese inhibitor saquinavir has been linked to increases in triglyceride and cholesterol concentration in patients undergoing long-term treatment. The lipodystrophy syndrome is seen mostly in patients using saquinavor in combination with Abbott Laboratories' ritonavir.

Published
1999

11. PEG-interferon more effective

Subjects
Roche Holding Ltd. -- Product information, Hepatitis C -- Drug therapy, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Pegasys (Medication) -- Evaluation
Published
1998

12. BfArM orders recall of Asta's mibefradil

Subjects
Germany. Federal Health Office -- Safety and security measures, Asta Medica AG -- Cases, Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Cases, Drug interactions -- Cases, Business, Pharmaceuticals and cosmetics industries, Posicor (Medication) -- Cases
Published
1998

13. CellCept endorsed for heart transplants

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Immunosuppressive agents -- Usage, Heart -- Transplantation, Business, Pharmaceuticals and cosmetics industries, CellCept (Medication) -- Usage
Published
1998

14. Viracept approved in Switzerland

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Management, HIV infection -- Drug therapy, Protease inhibitors -- Product information, Business, Pharmaceuticals and cosmetics industries
Published
1997

15. CSM on Fosamax & Lariam

Subjects
United Kingdom. Committee on Safety of Medicines -- Reports, Merck & Company Inc. -- Product information, Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Gastrointestinal agents -- Adverse and side effects, Mefloquine -- Adverse and side effects, Antimalarials -- Adverse and side effects, Alendronate -- Adverse and side effects, Business, Pharmaceuticals and cosmetics industries, Fosamax (Medication) -- Adverse and side effects, Lariam (Medication) -- Adverse and side effects
Published
1996

16. Combination AIDS trial starts

Subjects
Roche Holding Ltd. -- Product information, Abbott Laboratories (Abbott Park, Illinois) -- Product information, Pharmaceutical industry -- Research, Protease inhibitors -- Research, AIDS (Disease) -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1996

17. Protease inhibitors in France

Subjects
Roche Holding Ltd. -- Product information, HIV infection -- Drug therapy, Pharmaceutical industry -- Product information, Protease inhibitors -- Health aspects, Business, Pharmaceuticals and cosmetics industries
Published
1995

18. Protease inhibitor combinations for HIV?

Subjects
Abbott and Co. -- Product information, Roche Holding Ltd. -- Product information, HIV infection -- Drug therapy, Pharmaceutical industry -- Product information, Protease inhibitors -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1995

19. Advances with protease inhibitors

Subjects
Boehringer Ingelheim GmbH -- Product information, Agouron Pharmaceuticals Inc. -- Product information, Vertex Pharmaceuticals Inc. -- Product information, Glaxo Wellcome PLC -- Product information, Roche Holding Ltd. -- Product information, Merck & Company Inc. -- Product information, Pharmaceutical industry -- Product information, Protease inhibitors -- Research, HIV infection -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1995

20. First approvals for Roche's Vesanoid

Subjects
Roche Holding Ltd. -- Product information, Acute leukemia, Promyelocytic, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Vesanoid (Medication) -- Product introduction
Published
1995

21. Vesanoid data encouraging in APL

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Tretinoin -- Research, Acute leukemia, Promyelocytic -- Drug therapy, Antineoplastic agents -- Evaluation, Business, Pharmaceuticals and cosmetics industries, Vesanoid (Medication) -- Research
Published
1994

22. Zinecard/Vesanoid OK'd by FDA cm'tee

Subjects
Pharmacia Inc. -- Product information, Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Breast cancer -- Drug therapy, Acute leukemia, Promyelocytic -- Drug therapy, Antineoplastic agents -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1994

23. No Pulmozyme subsidy in Australia

Subjects
Roche Holding Ltd. -- Product information, Genentech Inc. -- Product information, Cystic fibrosis -- Drug therapy -- Finance, Pharmaceutical policy -- Australia, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication)
Published
1994

24. CPMP positive on Roferon for hep C

Subjects
Roche Holding Ltd. -- Product information, Hepatitis C -- Drug therapy, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries, European Union. Committee for Proprietary Medicinal Products -- Laws, regulations and rules -- Usage, Roferon-A (Medication)
Published
1994

25. Roche's Hivid launched in the UK

Subjects
United Kingdom -- Health aspects, Roche Holding Ltd. -- Product information, Zalcitabine -- Dosage and administration, AIDS (Disease) -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1994

26. Hivid for AIDS monotherapy in US

Subjects
Roche Holding Ltd. -- Product information, Zalcitabine -- Standards, AIDS (Disease) -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Hivid (Medication) -- Standards
Published
1994

27. Hivid now available under French social security

Subjects
Roche Holding Ltd. -- Product information, AIDS (Disease) -- Drug therapy, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Hivid (Medication) -- Laws, regulations and rules
Published
1994

28. Pulmozyme's EU expert report published

Subjects
Roche Holding Ltd. -- Product information, Genentech Inc. -- Officials and employees, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Reports
Published
1994

29. Recent product approvals in Switzerland

Subjects
Roche Holding Ltd. -- Product information, Abbott Laboratories (Abbott Park, Illinois) -- Product information, Hafslund Nycomed A/S -- Product information, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Laws, regulations and rules, Klacid (Medication) -- Laws, regulations and rules, Visipaque (Medication) -- Laws, regulations and rules
Published
1994

30. Italian CUF on Rocefin and fatal allergic reactions

Subjects
Italy -- Social policy, Roche Holding Ltd. -- Product information, Antibiotics -- Adverse and side effects, Business, Pharmaceuticals and cosmetics industries, Rocephin (Medication) -- Adverse and side effects
Published
1994

31. Roche's Pulmozyme approved in Spain

Subjects
Roche Holding Ltd. -- Product information, Cystic fibrosis -- Drug therapy, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Marketing
Published
1994

32. Fatal allergic reactions in Italian Rocefin patients

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Antibiotics -- Adverse and side effects, Ceftriaxone -- Adverse and side effects, Business, Pharmaceuticals and cosmetics industries, Rocephin (Medication) -- Adverse and side effects
Published
1994

33. FDA cm'ttee OKs Roche's fleroxacin

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Roche Holding Ltd. -- Product information, Drug approval -- Laws, regulations and rules, Pharmaceutical industry -- Product information, Quinolones -- Health aspects, Bacterial infections -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Megalone (Medication) -- Health aspects
Published
1994

34. Spanish reassurance on co-trimoxazole

Subjects
Wellcome PLC -- Product information, Roche Holding Ltd. -- Product information, The Sunday Times (London)(Newspaper) -- Reports, Co-trimoxazole -- Adverse and side effects, Antibacterial agents -- Adverse and side effects, Business, Pharmaceuticals and cosmetics industries, Septrin (Medication) -- Health aspects, Abactrin (Medication) -- Health aspects
Published
1994

35. Acitretin recommended for US approval

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Psoriasis -- Drug therapy, Acitretin -- Research, Dermatologic agents -- Research, Drug-alcohol interactions -- Research, Business, Pharmaceuticals and cosmetics industries, Soriatane (Medication) -- Research
Published
1994

36. Potential of moclobemide in anxiety disorders?

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Moclobemide -- Research, Panic disorders -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1994

37. Co-trimoxazole for PCP prophylaxis

Subjects
Roche Holding Ltd. -- Product information, Wellcome PLC -- Product information, Pharmaceutical industry -- Product information, Co-trimoxazole -- Health aspects, Pneumocystis carinii pneumonia -- Prevention, Business, Pharmaceuticals and cosmetics industries
Published
1994

38. Trends in Alzheimer market

Subjects
Warner-Lambert Co. -- Product information, Hoechst AG -- Product information, Sigma-Tau Pharmaceuticals Inc. -- Product information, Sandoz Ltd. -- Product information, Roche Holding Ltd. -- Product information, Glaxo Inc. -- Product information, Bayer AG -- Product information, Alzheimer's disease -- Drug therapy, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries
Published
1993

39. Hivid recommended for zidovudine failures in the US

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, AIDS (Disease) -- Drug therapy, Zidovudine -- Dosage and administration, Drug therapy, Combination -- Research, Business, Pharmaceuticals and cosmetics industries, Hivid (Medication) -- Dosage and administration
Published
1993

40. FDA committee OKs Hivid monotherapy

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Roche Holding Ltd. -- Product information, HIV infection -- Drug therapy, Antiviral agents -- Laws, regulations and rules, Business, Pharmaceuticals and cosmetics industries, Hivid (Medication) -- Laws, regulations and rules
Published
1993

41. Roche's Mazicon now Romazicon in the US

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Benzodiazepines -- Antagonists, Business, Pharmaceuticals and cosmetics industries, Mazicon (Medication) -- Names, Romazicon (Medication) -- Names
Published
1993

42. Roche/BMS discuss Inhibace brand name in Israel

Subjects
Roche Holding Ltd. -- Product information, Bristol-Myers Squibb Co. -- Product information, Pharmaceutical industry -- Product information, ACE inhibitors -- Names, Business, Pharmaceuticals and cosmetics industries, Inhibace (Medication) -- Marketing
Published
1993

44. New indications for alpha-interferon in Belgium

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Acute leukemia, Promyelocytic -- Drug therapy, Lymphomas -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Roferon-A (Medication) -- Usage
Published
1993

45. Recent product approvals in Denmark

Subjects
SmithKline Beecham Corp. -- Product information, Farmitalia Carlo Erba S.p.A. -- Product information, Roche Holding Ltd. -- Product information, Kabi Pharmacia AB -- Product information, Astra AB -- Product information, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Proscar (Medication) -- Marketing, Havrix (Vaccine) -- Marketing, Farmorubicin (Medication) -- Marketing, Neotigason (Medication) -- Marketing, Nicorette (Chewing gum) -- Marketing, Roxiam (Medication) -- Marketing
Published
1993

46. Antivirals in hepatitis B & C

Subjects
Roche Bioscience -- Product information, Ipsen-Biotech -- Product information, Roche Holding Ltd. -- Product information, Hepatitis B -- Drug therapy, Hepatitis C -- Drug therapy, Ganciclovir -- Research, Pharmaceutical industry -- Product information, Biotechnology industry -- Product information, Antiviral agents -- Research, Business, Pharmaceuticals and cosmetics industries, Roferon (Medication) -- Research
Published
1993

47. Recent product approvals in Switzerland

Subjects
Roche Holding Ltd. -- Product information, Klinge Pharma GmbH -- Product information, Astra AB -- Product information, Cephalosporins -- Marketing, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Globocef (Medication) -- Marketing, Aerocef (Medication) -- Marketing, Roxiam (Medication) -- Marketing
Published
1993

48. 1st US trial of new Roche AIDS drug

Subjects
United States. National Institute of Allergy and Infectious Diseases -- Research, Roche Holding Ltd. -- Product information, Protease inhibitors -- Research, HIV patients -- Drug therapy, Drug therapy, Combination -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1993

49. Perindropil and cilazapril now first-line in UK

Subjects
Servier Laboratories Ltd. -- Product information, Roche Holding Ltd. -- Product information, ACE inhibitors -- Health aspects, Hypertension -- Drug therapy, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries
Published
1993

50. Roche's protease inhibitor in US trials

Subjects
Roche Holding Ltd. -- Product information, Pharmaceutical industry -- Product information, Protease inhibitors -- Testing, AIDS (Disease) -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1993

Catalog

Books, media, physical & digital resources
See catalog results